Health In Tech, Inc. Class A Common Stock (HIT)vsNVIDIA Corporation (NVDA)
HIT
Health In Tech, Inc. Class A Common Stock
$1.07
+3.88%
TECHNOLOGY · Cap: $64.69M
NVDA
NVIDIA Corporation
$205.10
+0.16%
TECHNOLOGY · Cap: $5.40T
Smart Verdict
WallStSmart Research — data-driven comparison
NVIDIA Corporation generates 743620% more annual revenue ($253.49B vs $34.08M). NVDA leads profitability with a 63.0% profit margin vs -2.4%. NVDA earns a higher WallStSmart Score of 80/100 (A-).
HIT
Avoid29
out of 100
Grade: F
NVDA
Exceptional Buy80
out of 100
Grade: A-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HIT.
Margin of Safety
-71.9%
Fair Value
$119.30
Current Price
$205.10
$85.80 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Mega-cap, among the largest globally
Every $100 of equity generates 82 in profit
Keeps 63 of every $100 in revenue as profit
Strong operational efficiency at 65.6%
Revenue surging 85.2% year-over-year
Earnings expanding 214.5% YoY
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -3.7% — below average capital efficiency
Negative free cash flow — burning cash
Premium valuation, high expectations priced in
Weak financial health signals
Trading at 31.7x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : HIT
The strongest argument for HIT centers on Debt/Equity, Altman Z-Score.
Bull Case : NVDA
The strongest argument for NVDA centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 63.0% and operating margin at 65.6%. Revenue growth of 85.2% demonstrates continued momentum.
Bear Case : HIT
The primary concerns for HIT are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : NVDA
The primary concerns for NVDA are P/E Ratio, Piotroski F-Score, Price/Book.
Key Dynamics to Monitor
HIT profiles as a turnaround stock while NVDA is a growth play — different risk/reward profiles.
NVDA is growing revenue faster at 85.2% — sustainability is the question.
NVDA generates stronger free cash flow (48.6B), providing more financial flexibility.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
NVDA scores higher overall (80/100 vs 29/100), backed by strong 63.0% margins and 85.2% revenue growth. Both earn "Exceptional Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Health In Tech, Inc. Class A Common Stock
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Health In Tech, Inc. (HIT) is a leading innovator in the digital health sector, specializing in technology solutions that enhance healthcare delivery and patient outcomes. Utilizing advanced data analytics and proprietary software, HIT enables healthcare providers and patients to make informed decisions, thereby increasing operational efficiencies. The company’s strong commitment to compliance and cybersecurity positions it favorably within the rapidly growing digital health landscape. As the market continues to evolve, HIT is strategically positioned for growth, aiming to be a pivotal player in the global advancement of technology-driven healthcare solutions.
NVIDIA Corporation
TECHNOLOGY · SEMICONDUCTORS · USA
Nvidia Corporation is an American multinational technology company incorporated in Delaware and based in Santa Clara, California. It designs graphics processing units (GPUs) for the gaming and professional markets, as well as system on a chip units (SoCs) for the mobile computing and automotive market.
Visit Website →Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?